Tag Archives: Adults

FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults

FDA Approves Cablivi (caplacizumab-yhdp) for Acquired Thrombotic Thrombocytopenic Purpura (aTTP) in Adults Print this page February 6, 2019 — The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP),… Read More »

Cannabis abstinence tied to memory improvement in adolescents, young adults

(Reuters Health) – – Not using cannabis for a month could improve learning ability for adolescents and young adults who used the drug at least weekly, a U.S. study suggests. The study from Massachusetts General Hospital in Boston assessed 88 participants, ages 16 to 25, and found that not using cannabis for a month resulted… Read More »